Table 4.
Outcomes | Hazard ratio (95% CI) † | Pinteraction | ||
---|---|---|---|---|
All age | <50 years | ≥50 years | ||
Myocardial infarction | ||||
MetS-stable | 1 (reference) | 1 (reference) | 1 (reference) | 0.253 |
MetS-recovery | 0.62 (0.41–0.96) | 0.43 (0.18–1.06) | 0.73 (0.45–1.20) | |
Stroke | ||||
MetS-stable | 1 (reference) | 1 (reference) | 1 (reference) | 0.013 |
MetS-recovery | 0.59 (0.46–0.75) | 0.37 (0.21–0.64) | 0.69 (0.52–0.90) | |
Ischemic stroke | ||||
MetS-stable | 1 (reference) | 1 (reference) | 1 (reference) | 0.032 |
MetS-recovery | 0.58 (0.45–0.76) | 0.39 (0.22–0.70) | 0.66 (0.49–0.89) | |
Hemorrhagic stroke | ||||
MetS-stable | 1 (reference) | 1 (reference) | 1 (reference) | 0.129 |
MetS-recovery | 0.64 (0.34–1.21) | 0.18 (0.02–1.42) | 0.83 (0.42–1.64) | |
Heart failure | ||||
MetS-stable | 1 (reference) | 1 (reference) | 1 (reference) | 0.179 |
MetS-recovery | 0.56 (0.34–0.91) | 0.30 (0.09–1.04) | 0.63 (0.36–1.08) |
Stroke was the composite of ischemic stroke and hemorrhagic stroke.
Hazard ration was adjusted for age, sex, marital status, education level, smoking status, drinking status, physical activity level, salt intake, use of anti-hypertensive drug, anti-diabetic drug, lipid-lowering drug, and family history of myocardial infarction, stroke.
MetS, metabolic syndrome; CI, confidence interval.